Revenue | ₹14.25Cr |
Net Profits | ₹-4.93Cr |
Net Profit Margins | -34.60% |
Oxygenta Pharmaceutical Ltd’s revenue fell -3.39% since last year same period to ₹14.25Cr in the Q2 2025-2026. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated -6.86% fall in its revenue since last 3-months.
Oxygenta Pharmaceutical Ltd’s net profit fell -72.98% since last year same period to ₹-4.93Cr in the Q2 2025-2026. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated 19.31% jump in its net profits since last 3-months.
Oxygenta Pharmaceutical Ltd’s net profit margin fell -79.05% since last year same period to -34.60% in the Q2 2025-2026. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated 13.37% jumped in its net profit margins since last 3-months.
The revenue for Oxygenta Pharmaceutical Ltd in the Q2 results 2025 was ₹14.25Cr.
The net profit for Oxygenta Pharmaceutical Ltd in the Q2 results 2025 was ₹-4.93Cr.
The net profit margin for Oxygenta Pharmaceutical Ltd in the Q2 results 2025 was -34.60%.
The revenue for Oxygenta Pharmaceutical Ltd in the Q2 results 2024 was ₹14.75Cr.
The net profit for Oxygenta Pharmaceutical Ltd in the Q2 results 2024 was ₹-2.85Cr.
The net profit margin for Oxygenta Pharmaceutical Ltd in the Q2 results 2024 was -19.32%.